Raymund VincentSebastianSisonMD

Clinical Trials

• Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir Start of enrollment: 2008 Jul 01

  Completed

  Phase 3

• A Safety and Effectiveness Study of TMC435 in Chronic, Genotype 1, Hepatitis C Patients Who Failed to Previous Standard Treatment Start of enrollment: 2009 Oct 01

  Completed

  Phase 2

• Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults Start of enrollment: 2010 Mar 01

  Completed

  Phase 3

• Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults Start of enrollment: 2010 Apr 01

  Completed

  Phase 3

• Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults Start of enrollment: 2010 Apr 01

  Completed

  Phase 3

• A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults Start of enrollment: 2010 Oct 26

  Completed

  Phase 3

• A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial) Start of enrollment: 2011 Feb 01

  Completed

  Phase 3

• Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1 Start of enrollment: 2011 Sep 01

  Terminated

  Phase 3

• Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults Start of enrollment: 2011 Sep 01

  Completed

  Phase 3

• Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012) Start of enrollment: 2011 Nov 28

  Terminated

  Phase 2

• A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002) Start of enrollment: 2012 Feb 01

  Completed

  Phase 3

• A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007) Start of enrollment: 2012 Oct 12

  Completed

  Phase 2

• Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women Start of enrollment: 2012 Oct 24

  Completed

  Phase 3

• Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults Start of enrollment: 2012 Dec 26

  Completed

  Phase 3

• Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants Start of enrollment: 2013 Mar 27

  Completed

  Phase 3

• Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment Start of enrollment: 2013 Mar 27

  Completed

  Phase 3

• A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection Start of enrollment: 2013 Aug 30

  Completed

  Phase 2, Phase 3

• SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection Start of enrollment: 2013 Sep 24

  Completed

  Phase 3

• Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia Start of enrollment: 2013 Nov 01

  Completed

  Phase 3

• Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia Start of enrollment: 2013 Dec 01

  Completed

  Phase 2

• Join now to see all